Review: trends in nanotherapeutics to manage Helicobacter pylori
Antibiotics have been extensively used in the eradication of Helicobacter pylori, but their effectiveness is hindered by the bacterium’s ability to acquire resistance. Further, the drug’s short residence time and low bioavailability in the gastric environment (low pH, presence of digestive enzymes,...
Saved in:
Main Authors: | R. Chitas, P. Parreira, M.C. Martins |
---|---|
Format: | Article |
Language: | English |
Published: |
Verduci Editore
2024-09-01
|
Series: | Microbiota in Health and Disease |
Subjects: | |
Online Access: | https://www.microbiotajournal.com/wp-content/uploads/sites/7/2024/09/e1038.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeted Sonodynamic Therapy Platform for Holistic Integrative Helicobacter pylori Therapy
by: Xiaojing Yin, et al.
Published: (2025-01-01) -
The efficacy of quadruple therapy in non-ulcer Helicobacter Pylory gastritis in children: A prospective study
by: Hien Thi Phan, et al.
Published: (2025-01-01) -
Clinical and laboratory importance of detecting Helicobacter pylori coccoid forms for the selection
of treatment
by: Nikita Gladyshev, et al.
Published: (2020-12-01) -
Helicobacter pylori: pathogenesis
by: P. Sabanas, et al.
Published: (2024-09-01) -
High-dose dual therapy for Helicobacter pylori eradication inducing less impact on the gut microbiota
by: Jia-Lun Guan, et al.
Published: (2025-01-01)